Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 15,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.Pharmaron is a contract research organization (CRO).Services:* Synthetic, medicinal and analytical chemistry services* Biology services* DMPK services* Pharmacology services* Drug safety assessment services* Radiochemistry and isotopically labelled metabolism services* Chemical & pharmaceutical development services* Clinical development serviceswww.pharmaron.comCRO - Contract Research OrganizationLibrary SynthesisCADDBioorganic ChemistryDiscovery Process ChemistryRadiolabelled Chemical SynthesisChemInformaticsin vitro Biologyin vitro ScreeningStructural Biologyin vivo PharmacologyAnimal Disease Modelsex vivo Pharmacology Biomarkers in vitro ADME in vivo PKPKPDQARegulatory AffairsDiscovery BiologicsProcess ChemistryAPI ManufacturingMaterial ScienceFormulation DevelopmentDrug Product ManufacturingToxicologySafety PharmacologyGenetic ToxicologyDARTPathologyImmunotoxicity Bioanalytical14C / Carbon-14 Radiosynthesis3H / Tritium RadiosynthesisQWBAmARGClinical AME Mass BalanceMetabolite ProfilingMicrodosing Phase 0Absolute BioavailabilityDDIFirst-in-Human (FIH)Thorough QT(TQT)Ethnobridging

Chemistry Biology DMPK Pharmacology Chemical Development Preclinical Toxicology Safety Pharmacology Discovery Lead Optimization Process Development Assay Development ADME Formulation IND clinical pharmacology analytical sciences radiolabelled chemistry accelerator mass spectrometry radiolabelled compounds API manufacturing radiosynthesis B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals